Found: 1
Select item for more details and to access through your institution.
International Cost-Effectiveness Analysis of Durvalumab in Stage III Non–Small Cell Lung Cancer.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 5, p. e2413938, doi. 10.1001/jamanetworkopen.2024.13938
- By:
- Publication type:
- Article